Skip to Main Content

Paper Details

Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.
Sci Adv
14
2022
EZH2, EZH2i, MHC class II, UCa, advanced urothelial carcinoma, bladder cancer, histone methyltransferase EZH2, infiltrating T cells, mice, mouse, patients, tumor, urothelial carcinoma
Author NameAffiliation
Amy G RobertsonDxige Research Inc.
Amy G RobertsonDxige Research Inc.
Ali ShilatifardSimpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medicine
  • 1 - 3

Datasets

Release 1.2